Given the known impact of plasma cholesterol levels on cardiovascular disease, determining whether V227A reduces LDL or remnant cholesterol levels and whether LPL-mediated plasma cholesterol reduction yields any protection from atherosclerosis would be worth future investigation. Here, LPL is linked to cardiovascular disorder.